Effects of hydrophobic and hydrophilic drugs on NaChBac activation and inactivation
| Effects on activation of NaChBac | Effects on inactivation of NaChBac | |||||||||||
| Ranolazine (200 μM) | Lidocaine (1 mM) | Benzocaine (1 mM) | Ranolazine (200 μM) | Lidocaine (1 mM) | Benzocaine (1 mM) | |||||||
| V1/2 | dx | V1/2 | dx | V1/2 | dx | V1/2 | dx | V1/2 | dx | V1/2 | dx | |
| mV | mV | mV | mV | mV | mV | mV | mV | mV | mV | mV | mV | |
| Control | −19.8 ± 1.4a | 11.1 ± 0.6a | −26.5 ± 2.8a | 10.4 ± 0.4 | −17.9 ± 2.1 | 9.8 ± 0.2 | −50.8 ± 0.6a | 6.2 ± 1.0 | −52.0 ± 1.6a | 5.9 ± 0.5 | −44.7 ± 0.8a | 7.0 ± 0.2 |
| Drug | −32.8 ± 2.1a | 6.2 ± 0.6a | −30.5 ± 2.6a | 10.9 ± 0.8 | −21.1 ± 5.9 | 10.0 ± 1.5 | −57.9 ± 0.4a | 6.8 ± 0.6 | −62.1 ± 1.1a | 5.8 ± 0.4 | −58.9 ± 0.8a | 6.9 ± 0.4 |
| Effects on activation of NaChBac | Effects on inactivation of NaChBac | |||||||||||
| Ranolazine (200 μM) | Lidocaine (1 mM) | Benzocaine (1 mM) | Ranolazine (200 μM) | Lidocaine (1 mM) | Benzocaine (1 mM) | |||||||
| V1/2 | dx | V1/2 | dx | V1/2 | dx | V1/2 | dx | V1/2 | dx | V1/2 | dx | |
| mV | mV | mV | mV | mV | mV | mV | mV | mV | mV | mV | mV | |
| Control | −19.8 ± 1.4a | 11.1 ± 0.6a | −26.5 ± 2.8a | 10.4 ± 0.4 | −17.9 ± 2.1 | 9.8 ± 0.2 | −50.8 ± 0.6a | 6.2 ± 1.0 | −52.0 ± 1.6a | 5.9 ± 0.5 | −44.7 ± 0.8a | 7.0 ± 0.2 |
| Drug | −32.8 ± 2.1a | 6.2 ± 0.6a | −30.5 ± 2.6a | 10.9 ± 0.8 | −21.1 ± 5.9 | 10.0 ± 1.5 | −57.9 ± 0.4a | 6.8 ± 0.6 | −62.1 ± 1.1a | 5.8 ± 0.4 | −58.9 ± 0.8a | 6.9 ± 0.4 |
Mean ± SEM is given.
Statistical significance was set at P < 0.05.